Forward Industries, Inc. (FORD) - Q3 2024 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2024. Forward Industries, Inc. operates two primary segments: OEM Distribution (sourcing and selling carrying cases/accessories for medical and electronic devices) and Design (hardware and software engineering services). The Company ceased operations of its retail distribution segment in July 2023, reporting those results as discontinued operations. A 1-for-10 reverse stock split became effective on June 18, 2024.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | Q3 2023 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|---|
| Total Revenues | $7.89 million | $8.71 million | $22.87 million | $28.20 million |
| Gross Profit | $1.61 million | $2.19 million | $4.86 million | $6.08 million |
| Gross Margin | 20.4% | 25.2% | 21.2% | 21.6% |
| Operating Loss | $(0.38) million | $0.15 million (Income) | $(1.30) million | $(0.07) million |
| Net Loss | $(0.40) million | $(0.54) million | $(1.31) million | $(1.84) million |
| Cash and Equivalents | $2.56 million | (Balance Sheet Data) | ||
| Working Capital | $(1.58) million (Deficit) | (Excludes discontinued assets) | ||
| Related Party Debt | $9.90 million (Total) | (Includes Note & Payables) |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 9.4% quarter-over-quarter and 18.9% year-to-date. The OEM Distribution segment saw a 32.9% YTD revenue drop, primarily due to the loss of a major diabetic customer in March 2023 and declining demand for carrying cases. The Design segment revenue fell 1.1% QoQ and 9.4% YTD, driven by lower utilization rates and a significant revenue drop from one major customer.
- Margin Compression: Gross margin declined to 20.4% in Q3 2024 from 25.2% in the prior year quarter, attributed to lower utilization in the Design segment. Operating margins in the Design segment fell from 10.0% to 1.1%.
- Discontinued Operations: The Company liquidated remaining retail inventory by June 30, 2024. Loss from discontinued operations was minimal in Q3 2024 ($23,000) compared to significant losses in the prior year ($670,000).
- Stock Structure: A 1-for-10 reverse stock split was executed in June 2024 to regain Nasdaq compliance.
Outlook, Risks, and Management Commentary
- Liquidity and Debt: The Company has a working capital deficit of approximately $1.58 million. It holds a $600,000 promissory note to Forward China (related party) maturing December 31, 2024. To preserve liquidity, Forward China agreed to limit collection of outstanding payables to $500,000 per 12-month period. Additionally, $1.7 million of payables was converted into Series A-1 Convertible Preferred Stock in July 2024.
- Nasdaq Compliance: The Company regained compliance with Nasdaq listing standards in July 2024 following the reverse stock split and debt conversion. It remains under a "Panel Monitor" until July 24, 2025.
- Future Outlook: Management expects diabetic product sales to continue declining as a portion of OEM revenue. They anticipate existing cash and working capital will be sufficient through August 31, 2025, though they may implement further cost-cutting measures (labor reductions) if necessary.
- Risks: Key risks include customer concentration (one customer represented 23.9% of Q3 revenue), reliance on Forward China for sourcing, and the potential inability to maintain Nasdaq listing standards if shareholder equity requirements are not met.
Investor Verification Checklist
- Debt Maturity: Verify the repayment plan for the $600,000 Forward China promissory note due December 31, 2024.
- Customer Concentration: Assess the risk associated with the Design segment's top customer, which accounted for 23.9% of Q3 revenues.
- Related Party Transactions: Review the terms of the Accounts Payable Conversion Agreement and the ongoing sourcing agreement with Forward China (CEO-owned entity).
- Working Capital: Monitor the working capital deficit and cash burn rate to ensure sufficiency through the projected liquidity horizon.
- Nasdaq Status: Confirm continued compliance with Nasdaq shareholder equity requirements during the monitoring period.